ADXS-503

· Advaxis, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ADXS-503, covering 2024-06-04 to 2024-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing